A detailed history of Mokosak Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mokosak Advisory Group, LLC holds 934 shares of AMGN stock, worth $264,891. This represents 0.09% of its overall portfolio holdings.

Number of Shares
934
Previous 927 0.76%
Holding current value
$264,891
Previous $289,000 3.81%
% of portfolio
0.09%
Previous 0.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$309.38 - $337.38 $2,165 - $2,361
7 Added 0.76%
934 $300,000
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $16,816 - $20,435
64 Added 7.42%
927 $289,000
Q1 2024

Apr 29, 2024

BUY
$268.87 - $324.56 $1,882 - $2,271
7 Added 0.82%
863 $245,000
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $1,789 - $2,019
7 Added 0.82%
856 $246,000
Q3 2023

Oct 19, 2023

BUY
$218.65 - $271.46 $185,633 - $230,469
849 New
849 $228,000
Q4 2022

Feb 02, 2023

BUY
$229.03 - $291.01 $177,269 - $225,241
774 New
774 $203,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mokosak Advisory Group, LLC Portfolio

Follow Mokosak Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mokosak Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mokosak Advisory Group, LLC with notifications on news.